The Suzhou-based firm plans to use the money to advance its therapies, currently in clinical development in China and Australia.
Article Source: China’s Alphamab raises $100M in Series A financing from US, Asian investors.
China’s Alphamab raises $100M in Series A financing from US, Asian investors
Article Source: China’s Alphamab raises $100M in Series A financing from US, Asian investors.
0 Comments